8-K
Current Report
Taysha Gene Therapies, Inc. Filed Acc 0001193125-25-133745
Bylaws or fiscal year change · Shareholder vote results
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d843671d8k.htm…